🔗 Share this article

An underground economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are urged to message these accounts directly for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on Telegram, where communities with thousands of members share comparison images, administration instructions and assertions of rapid British shipping. Vendors promote the drug there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, physicians and chemists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Several experts stated the demand for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or prison.

Service Reaction and Content Removal

Based on the social media company, the service has removed problematic material and banned related hashtags and search suggestions. The company stated it was dedicated to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Investigations also found groups with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up groups with thousands of members, filled with photos of weight loss, positive testimonials and detailed guides for preparing or administering at home.

Within moments of joining one group, a seller shared contact information, where most transactions take place. The seller provided an guidebook and promised shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about body mass, medical conditions or previous experience.

Product Details and Costs

Inside these communities, posts show black plastic packages with Royal Mail labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or pre-filled pens usually priced at £160 for 20mg. When questioned how long a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for Telegram said it actively moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they can’t verify. Although the science behind this drug is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has previously encountered individuals harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to potentially significant medical dangers”.